MeasuredReferenceAfatinib targets ERBB4_HER4, EGFR, ERBB2_HER2. Strongest hallmark effect: tumor promoting inflammation.
Top hallmarks
- tumor promoting inflammation3.7k
- evading apoptosis2.9k
- proliferation2.8k
Top pathways disrupted
- allograft rejection7.0k
- apical junction6.9k
- pi3k akt mtor signaling6.3k
Resistance landscape — Afatinib
MeasuredReference10 known oncogenic variants exist on Afatinib's top targets — see detail for inhibition impact.